VNDA — Vanda Pharmaceuticals Share News
0.000.00%
Last trade - 00:00- $244.87m
- $82.02m
- $216.11m
US FDA approves Vanda's psychiatric drug
NASDAQ TRADE HALT HALT NEWS PENDING AT 04:17 PM
Brief: Vanda Pharmaceuticals Inc Files For Mixed Shelf Offering Of Upto $200 Million - SEC Filing
Vanda Pharmaceuticals Q4 revenue rises 8% on Fanapt sales
U.S. STOCKS ON THE MOVE-DoorDash, Duolingo, Gap
U.S. STOCKS ON THE MOVE-Bloom Energy, Tyson Foods, Voyager Technologies
U.S. STOCKS ON THE MOVE-Sigma Lithium, Darden Restaurants, Nike
Vanda falls as US FDA rejects jet lag drug application
Newscasts - Wall Street ends 2025's final session lower but posts big annual gains
US STOCKS-Wall Street ends year's final session lower but ends 2025 with big annual gains
US STOCKS-Wall Street drops on tech, set to see annual gains
U.S. STOCKS ON THE MOVE-Boeing, GlobalFoundries, Marriott
U.S. STOCKS ON THE MOVE-Oil producers, media stocks, US transport stocks, US airlines
U.S. STOCKS ON THE MOVE-EV stocks, Chipmakers, Medtech, Copper and Lithium miners
U.S. STOCKS ON THE MOVE-Nike, silver and gold miners, Vanda Pharma, Tesla
U.S. RESEARCH ROUNDUP-Nextera Energy, Nextpower, TKO Group
Vanda Pharma jumps after US FDA approves motion sickness drug
US FDA approves Vanda Pharmaceuticals' motion sickness drug (updated)
Brief: Vanda Pharmaceuticals Announces FDA Approval Of Nereus (Tradipitant)